| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
3e-05 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.21 |
5e-05 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |